Your search for comorbidities returned 103 results

Investigators sought to identify risk factors and develop a predictive risk score for new pacemaker implantation after transcatheter aortic valve replacement.

Researchers assessed the association between long-term usage of PPIs and the adverse events of dementia, pneumonia, intestinal infections, and chronic kidney disease.

In patients with heart failure with preserved ejection fraction, pulmonary disease may be an independent predictor of all-cause and heart failure hospitalizations.

Advanced interatrial block is a favorable parameter to estimate the presence of low voltage area and it may provide useful information for the treatment strategy for atrial fibrillation and the prediction of the outcome after ablation.

Patients with monitoring device like pacemaker had a significantly increased risk of being diagnosed with AF in comparison to general population with no difference in incidence of AF when 2 different monitoring devices were compared.

The researchers sought to determine whether an interatrial shunt device would improve pulmonary artery function at rest and during exercise in patients without heart failure without lessening systemic blood flow.

The rate of complications and in-hospital mortality was found to be high in patients undergoing transcutaneous lead extraction for implantable device-related infections.

US and European guidelines for the diagnosis and management of syncope are similar.

Early mortality after atrial fibrillation ablation may be predicted by the occurrence of heart failure, procedural complications, as well as low hospital AF ablation.

Preferential use of angiotensin-converting enzyme inhibitors over angiotensin receptor blockers should be considered whenever possible, particularly in patients with severe mental health illness.